Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease pulmonary embolism
Symptom C0042487|deep vein thrombosis
Sentences 41
PubMedID- 25004024 Treatment of deep vein thrombosis in patients with pulmonary embolism: subgroup analysis on the efficacy and safety of certoparin vs.
PubMedID- 20934671 Looking for asymptomatic pulmonary embolism in patients with deep vein thrombosis: is it the right practice.
PubMedID- 20222389 We report a case of deep vein thrombosis leading to progressive massive pulmonary embolism despite appropriate anticoagulation, where thrombolysis with ivc filter placement resulted in a successful outcome.
PubMedID- 20435232 Background: desirudin, a bivalent direct thrombin inhibitor (dti), is approved by the us food and drug administration for the prevention of deep vein thrombosis, which may lead to pulmonary embolism, in patients undergoing elective hip replacement surgery.
PubMedID- 23818798 Three new oral anticoagulants, the direct thrombin inhibitor, dabigatran etexilate, and the factor xa inhibitors, rivaroxaban and apixaban, have been approved in the us for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; rivaroxaban is also approved for prophylaxis and treatment of deep vein thrombosis, which may lead to pulmonary embolism in patients undergoing knee or hip replacement surgery.
PubMedID- 23831989 The occurrence of deep vein thrombosis with subsequent pulmonary embolism can be reduced by consistent prophylaxis.
PubMedID- 23204874 It should be noted that there were single events of gastrointestinal bleeding and deep vein thrombosis with pulmonary embolism.
PubMedID- 21679973 Early tec included 2 cases of myocardial infarction, one of acute coronary syndrome, one of deep vein thrombosis (dvt) with pulmonary embolism and one of isolated dvt.
PubMedID- 26029307 Large diverticulum of the urinary bladder: a rare cause of deep vein thrombosis with consecutive pulmonary embolism.
PubMedID- 23903304 The prevalence of isolated calf deep vein thrombosis in patients with pulmonary embolism.
PubMedID- 23106054 Lower limb deep vein thrombosis in patients with suspected pulmonary embolism detected with (99m)tc-maa simultaneously with lung perfusion scan.
PubMedID- 22288520 Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs.
PubMedID- 22865417 Anticoagulation therapy for postoperative deep vein thrombosis coupled with pulmonary embolism: a potential trigger for delayed popliteal artery injury presentation after total knee arthroplasty.
PubMedID- 26190336 We have listed 10 cases of immediate pulmonary thromboembolism and 16 cases of deep vein thrombosis complicated with pulmonary embolism in 6 cases.
PubMedID- 24657810 Bemiparin is a low molecular weight heparin (lmwh) indicated for the acute treatment of deep vein thrombosis with or without pulmonary embolism, for the prophylaxis of venous thromboembolism in surgical and non-surgical patients and for the prevention of clotting in the extracorporeal circuit during hemodialysis.
PubMedID- 20110556 Rationale: concomitant deep vein thrombosis (dvt) in patients with acute pulmonary embolism (pe) has an uncertain prognostic significance.
PubMedID- 23806169 In addition, rivaroxaban is approved for the treatment deep vein thrombosis without pulmonary embolism in canada or deep vein thrombosis with or without pulmonary embolism in the us 1.
PubMedID- 26146200 Relationship between mean platelet volume and pulmonary embolism in patients with deep vein thrombosis.
PubMedID- 22076115 One serious adverse event was considered potentially treatment-related, ie, deep vein thrombosis with pulmonary embolism (described above), which occurred in one patient during the randomized controlled trial preceding this open-label study.
PubMedID- 22876743 Objective: to report a case of deep vein thrombosis (dvt) with symptomatic pulmonary embolism (pe) possibly associated with the use of coltsfoot, kava, or blue vervain.
PubMedID- 20577781 11 cases; ischemic stroke 9 cases; peripheral arteries 3 cases; deep vein thrombosis with or without pulmonary embolism 17 cases; thrombosis in other veins 3 cases.
PubMedID- 22577900 Introduction: arterial and venous thrombotic states, including myocardial infarction (mi), stroke and deep vein thrombosis with subsequent pulmonary embolism, are a significant cause of cardiovascular mortality and morbidity.
PubMedID- 23210584 Optional inferior vena cava (ivc) filters are being increasingly used for protection against pulmonary embolism in patients with deep vein thrombosis where anticoagulation is contraindicated.
PubMedID- 20131193 A case of a patient with surgically treated progressive thromboembolic pulmonary hypertension in the course of recurrent pulmonary embolism resulting from deep vein thrombosis is presented.
PubMedID- 25594352 Two venous thrombotic events were recorded in the rhufviia arm: one ovarian vein thrombosis and one deep vein thrombosis with a non-severe pulmonary embolism.
PubMedID- 23674896 The einstein-pe study62 was a randomized, open-label, event-driven, noninferiority trial involving 4832 patients who had acute symptomatic pulmonary embolism with or without deep vein thrombosis.
PubMedID- 22183247 Approximately 30% of the apparently isolated episodes of pulmonary embolism are associated with silent deep vein thrombosis (2).
PubMedID- 26015639 Background: deep vein thrombosis leading to pulmonary embolism is one of the major complication after fracture.
PubMedID- 21930318 Background: chronic thromboembolic pulmonary hypertension (cteph) has been considered to be caused by single or recurrent pulmonary embolism (pe) arising from deep vein thrombosis (dvt).
PubMedID- 25487168 Background: asymptomatic or silent pulmonary embolism (s-pe) in patients with deep vein thrombosis has been the focus of numerous publications with the objective of determining the incidence of s-pe and assessing whether its existence has any clinical or therapeutic consequences that outweigh the risks associated with the diagnostic tests performed and the increased healthcare costs.
PubMedID- 25485923 Similar indications include reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation for all 3 agents, for the prevention of deep vein thrombosis that may lead to pulmonary embolism in patients undergoing hip or knee surgery for rivaroxaban and apixaban, and for the treatment and prevention of deep vein thrombosis and pulmonary embolism.
PubMedID- 25901228 One important complication seen in our series of patients who underwent mi-tlif included a patient with a deep vein thrombosis leading to a pulmonary embolism.
PubMedID- 21569584 deep vein thrombosis with pulmonary embolism and constipation due to obstructive defecation have been reported.
PubMedID- 20598461 Results: of 5889 patients, 426 had pulmonary embolism (pe) with deep vein thrombosis (dvt), 148 had pe without dvt, and 5315 had no vte.
PubMedID- 24625511 One patient developed deep vein thrombosis with pulmonary embolism; however, outcome was favorable.
PubMedID- 23109209 Subsequently the patient has developed deep vein thrombosis with pulmonary embolism.
PubMedID- 24754745 Results: a total of 19 thromboembolic events were identified - 13 deep vein thrombosis and 6 with pulmonary embolism.
PubMedID- 21406312 Background: it has been generally accepted that chronic thromboembolic pulmonary hypertension (cteph) results from pulmonary embolism arising from deep vein thrombosis.
PubMedID- 23328473 Analysis of causative factors for lower limb deep vein thrombosis complicated with artery pulmonary embolism in orthopedics patients.
PubMedID- 21036692 In addition to the primary vte outcome, pulmonary embolism (without coincident deep vein thrombosis) and deep vein thrombosis (without coincident pulmonary embolism) were also examined to evaluate their individual associations with pm and interactions between pm and hormone therapy.
PubMedID- 22963114 Associations were similar for deep vein thrombosis with and without pulmonary embolism.

Page: 1